Home › Funds › Morgan Stanley › CMPX

Morgan Stanley position in CMPX

COMPASS THERAPEUTICS INC · Health Care

Latest position (Q2 2026)735.19K sh
Reported value held$1.61M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q4 2021 17.47K $56.00K New
Q1 2022 26.98K $37.00K Add
Q2 2022 613 $2.00K Reduce
Q3 2022 8.87K $20.00K Add
Q4 2022 64.50K $324.43K Add
Q1 2023 160.06K $523.41K Add
Q2 2023 118.90K $378.09K Reduce
Q3 2023 63.29K $124.68K Reduce
Q4 2023 227.99K $355.67K Add
Q1 2024 164.23K $325.18K Reduce
Q2 2024 167.92K $167.92K Add
Q3 2024 377.89K $695.31K Add
Q4 2024 378.55K $548.90K Hold
Q1 2025 839.18K $1.59M Add
Q1 2025 839.18K $1.59M Add
Q2 2025 248.75K $646.75K Reduce
Q2 2025 248.75K $646.75K Reduce
Q3 2025 186.95K $654.33K Reduce
Q4 2025 365.25K $1.96M Add
Q1 2026 360.37K $1.91M Reduce
Q2 2026 735.19K $1.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding CMPX

All CMPX fund holders →